Stability of Dabigatran Etexilate in Manufacturer’s Blister Pack, Unit-Dose Packaging, and Community Pharmacy Blister Pack

BACKGROUND: Dabigatran, a direct thrombin inhibitor, is indicated for the prevention and treatment of venous thromboembolism and for stroke prophylaxis in atrial fibrillation. The manufacturer recommends that dabigatran etexilate be retained in the original packaging until administration. Currently,...

Full description

Saved in:
Bibliographic Details
Published in:Can J Hosp Pharm
Main Authors: Wang, Erica H Z, Bolt, Jennifer L, Décarie, Diane, Semchuk, William, Ensom, Mary H H
Format: Artigo
Language:Inglês
Published: Canadian Society of Hospital Pharmacists 2015
Subjects:
Original Research / Recherche Originale
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350494/
https://ncbi.nlm.nih.gov/pubmed/25762815
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items